Modern Vascular Opens New Outpatient Cath Lab to Treat Peripheral Artery Disease
An interventional radiologist consults with a patient in an out patient cath lab at a Modern Vascular clinic. The company is building several out patient clinics to capture a share of the interventional market for peripheral artery disease (PAD) catheter-based therapies.
February 3, 2021 Modern Vascular is a medical group that has 13 outpatient cath lab clinics to treat peripheral artery disease (PAD) and prevent lower limb amputations. The company announced the expansion of its national footprint with the opening of an office in Richmond, Texas. The company will also soon be opening clinics in Indianapolis, Houston, St. Louis and Kansas City.
Routine vaccinations in India disrupted by the COVID-19 pandemic
In less than three months from its detection, the World Health Organization (WHO) declared the outbreak of the coronavirus disease 2019 (COVID-19) a pandemic. COVID-19’s causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is highly infective. To date, over 103 million cases have been reported, with over 2.23 million deaths.
At various points in the pandemic’s trajectory, the rapid spread of COVID-19 across many parts of the world have forced numerous nations into a string of lockdowns. In India, lockdown measures have resulted in major disruptions to essential health services, including routine immunization drives for children. Such interruptions during previous epidemics have led to outbreaks of vaccine-preventable diseases, amplifying morbidity and mortality.
New mobile resource bringing services to America s amputee community
and last updated 2021-01-20 16:13:56-05
Itâs hard to keep Robert Falls off his feet, despite injury or amputation.
âI want to live as long as I possibly can,â he said.
After dealing with diabetes for years, Falls recently had his right leg removed below the knee, making him one of the two million Americans who are dealing with life after amputation.
After the operation, Falls was learning to get around well on his own until COVID-19 hit, which made it harder to get to the hospital.
âLike taking a walk,â he said. âI didnât think I was going to be able to do that anymore.â
Share this article
Share this article
CLEVELAND and ALISO VIEJO, Calif., Jan. 7, 2021 /PRNewswire/ Neuros Medical, Inc., a medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, announced today the achievement of two milestones in its pivotal QUEST (High-Fre
QUEncy Nerve Block for Po
ST-Amputation Pain) study. QUEST is a 180-subject, randomized, double blinded, active sham controlled clinical trial that is being conducted under an Investigational Device Exemption (IDE). QUEST is designed to assess the safety & effectiveness of the Company s Altius
® High-Frequency Nerve Block system to treat intractable post-amputation pain. Post-amputation pain is a significant unmet medical need, as existing treatment options are limited, and consist primarily of opioids and gabapentinoids.
Press release content from Business Wire. The AP news staff was not involved in its creation.
ATI Physical Therapy Launches Specialized Limb Loss Treatment Program Following Successful Pilot
December 14, 2020 GMT
BOLINGBROOK, Ill. (BUSINESS WIRE) Dec 14, 2020
ATI Physical Therapy (ATI), one of the nation’s largest providers of physical therapy services, today announced the launch of new limb loss specialty centers that expand the use of outpatient physical therapy and creates a stronger care continuum for patients who are scheduled to undergo limb loss surgery or have experienced limb loss.
ATI developed the specialty program and centers of excellence in partnership with Hanger Clinic, a leading orthotic and prosthetic provider, to deliver patients individualized and compassionate care that improves functional outcomes and helps them navigate their new normal. ATI’s skilled PTs and OTs will join physicians and prosthetists on the forefront of each patient’s rehabilitation